文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

高等院校女学生对长效注射用艾滋病病毒暴露前预防药物用于艾滋病预防的知晓度与可接受性:一项多中心、基于机构的横断面研究

Awareness and acceptability of long-acting injectable pre-exposure prophylaxis for HIV prevention among female students at tertiary learning institutions: a multi-center, institution-based cross-sectional study.

作者信息

Kampamba Martin, Munawai Pumulo, Sioma Remmy, Hikaambo Christabel Mwila, Mudenda Steward, Mutenda Mukumbi, Mukumbuta Jean M, Hampango Muchindu, Malambo Muzyamba, Mwalungali Gunet, Hamachila Audrey, Chabalenge Billy, Hangoma Jimmy, Ngula Mashebe Innocent, Appiah Bernard

机构信息

School of Health Sciences, Department of Pharmacy, University of Zambia, Lusaka, Zambia.

Department of Pharmacy, Children's Hospital, University Teaching Hospitals, Lusaka, Zambia.

出版信息

BMC Public Health. 2025 Jul 17;25(1):2478. doi: 10.1186/s12889-025-22271-9.


DOI:10.1186/s12889-025-22271-9
PMID:40676534
Abstract

BACKGROUND: Adolescent girls and young women (AGYW) in Zambia face an elevated risk of acquiring HIV. Long-acting injectable pre-exposure prophylaxis (LAI-PrEP) is an effective scientific method to prevent new HIV infections. However, awareness and acceptability of LAI-PrEP among AGYW remain limited. Thus, we aimed to assess awareness and acceptability of LAI-PrEP among female students. METHODS: This multi-center, institution-based cross-sectional study involved 760 female students from three universities in Lusaka, Zambia. Data were collected using a structured, self-administered questionnaire. Questions on acceptability and awareness were presented in a yes/no format. Data analysis was performed using STATA version 15.1. RESULTS: Of the 760 participants, less than half, 349 (45.9%), were aware of injectable PrEP, with lectures being the most common source of information. In terms of acceptability, 531 (69.9%) of respondents indicated they would be willing to take LAI-PrEP once available. Biomedical science students were significantly less likely to accept injectable PrEP (AOR = 0.10, CI: 0.01-0.94, p = 0.044), as were those not at risk of HIV in the past three months (AOR = 0.41, CI: 0.21-0.81, p = 0.011). Conversely, knowing a partner's HIV status (AOR = 2.52, CI: 1.27-4.98, p = 0.0001) and being at risk of HIV in the past three months (AOR = 3.4, CI: 1.78-7.81, p = 0.011) were significantly associated with LAI-PrEP acceptability. CONCLUSION: The study revealed a notable gap in awareness of LAI-PrEP among participants, with less than half being informed about its existence. Despite this low awareness, a significant majority expressed a willingness to accept LAI-PrEP if it were made available to them. This indicates a strong potential for adoption of LAI-PrEP, contingent upon improved education and awareness efforts.

摘要

背景:赞比亚的青春期女孩和年轻女性感染艾滋病毒的风险较高。长效注射暴露前预防(LAI-PrEP)是预防新发艾滋病毒感染的一种有效科学方法。然而,青春期女孩和年轻女性对LAI-PrEP的知晓度和接受度仍然有限。因此,我们旨在评估女学生对LAI-PrEP的知晓度和接受度。 方法:这项多中心、基于机构的横断面研究涉及赞比亚卢萨卡三所大学的760名女学生。数据通过结构化的自填问卷收集。关于接受度和知晓度的问题采用是/否格式呈现。使用STATA 15.1版进行数据分析。 结果:在760名参与者中,不到一半,即349人(45.9%)知晓注射用PrEP,讲座是最常见的信息来源。在接受度方面,531名(69.9%)受访者表示一旦有LAI-PrEP,她们愿意使用。生物医学专业的学生接受注射用PrEP的可能性显著较低(调整后比值比[AOR]=0.10,置信区间[CI]:0.01-0.94,p= 0.044),过去三个月无艾滋病毒感染风险的学生也是如此(AOR=0.41,CI:0.21-0.81,p=0.011)。相反,了解伴侣的艾滋病毒感染状况(AOR=2.52,CI:1.27-4.98,p=0.0001)以及过去三个月有艾滋病毒感染风险(AOR=3.4,CI:1.78-7.81,p=0.011)与LAI-PrEP的接受度显著相关。 结论:该研究揭示了参与者对LAI-PrEP知晓度方面存在显著差距,不到一半的人了解其存在。尽管知晓度较低,但绝大多数人表示如果有LAI-PrEP可供使用,他们愿意接受。这表明在加强教育和提高知晓度的努力下,LAI-PrEP具有很强的采用潜力

相似文献

[1]
Awareness and acceptability of long-acting injectable pre-exposure prophylaxis for HIV prevention among female students at tertiary learning institutions: a multi-center, institution-based cross-sectional study.

BMC Public Health. 2025-7-17

[2]
Factors associated with awareness of and willingness to use PrEP among stable, heterosexual HIV-serodifferent couples in seven African countries, 2019-2022.

J Int AIDS Soc. 2025-6

[3]
Preferences for on-demand/intermittent/event-driven and long-acting injectable (LAI) HIV pre-exposure prophylaxis (PrEP) among HIV-negative Black gay, bisexual, and other sexual minority men in the United States: A qualitative study.

PLoS One. 2025-6-30

[4]
Awareness and intention to use event-driven and long-acting injectable pre-exposure prophylaxis among adolescent and young men who have sex with men and transgender women in Brazil: a cross-sectional study.

J Int AIDS Soc. 2025-7

[5]
A Mixed Methods Evaluation of Pharmacists' Readiness to Provide Long-Acting Injectable HIV Pre-exposure Prophylaxis in California.

J Acquir Immune Defic Syndr. 2024-10-1

[6]
Safety, tolerability, and acceptability of long-acting injectable cabotegravir for HIV prevention in cisgender female adolescents (HPTN 084-01): a single-arm, open-label, phase 2b trial.

Lancet HIV. 2025-4

[7]
Inequities in HIV prevention among trans and/or non-binary people: a cross-sectional survey analysis of PrEP and PEP awareness and use in Spain.

Int J Equity Health. 2025-7-7

[8]
PrEP15-19 Choices: an implementation study protocol of HIV prevention with oral and long-acting injectable cabotegravir PrEP in real-word settings among sexual and gender minority adolescents in Brazil.

BMJ Open. 2025-1-20

[9]
Factors associated with PEP awareness among adolescent girls and young women in Eswatini.

J Int AIDS Soc. 2025-6

[10]
High Preference for Injectable Pre-exposure Prophylaxis among Young Women in Kenya.

AIDS Behav. 2025-3-24

本文引用的文献

[1]
Awareness and intention to use event-driven and long-acting injectable pre-exposure prophylaxis among adolescent and young men who have sex with men and transgender women in Brazil: a cross-sectional study.

J Int AIDS Soc. 2025-7

[2]
Willingness to Use Long-Acting Injectable PrEP Among PrEP Naïve Black and Hispanic Sexual Gender Minority Persons.

AIDS Behav. 2024-6

[3]
Intersecting epidemics: COVID-19 and HIV in sub-Saharan Africa. A systematic review (2020-2022).

J Public Health Afr. 2023-10-1

[4]
Willingness to use long-acting injectable PrEP among HIV-negative/unknown men who have sex with men in mainland China: A cross-sectional online survey.

PLoS One. 2023

[5]
Oral Pre-exposure Prophylaxis Uptake and Acceptability Among Men Who Have Sex With Men: A Scoping Review of the Literature.

Am J Mens Health. 2023

[6]
Systematic review of the values and preferences regarding the use of injectable pre-exposure prophylaxis to prevent HIV acquisition.

J Int AIDS Soc. 2023-7

[7]
Predictors of PrEP awareness, PrEP discussion and interest in long-acting injectable PrEP among Filipina transfeminine adults.

J Int AIDS Soc. 2023-6

[8]
Exploring communication and implementation challenges of the HIV/AIDS policy change to test-and-treat-all in selected public health facilities in Lusaka District, Zambia.

Implement Sci Commun. 2023-5-12

[9]
High Interest in Long-acting Injectable Pre-exposure Prophylaxis (LAI-PrEP) for HIV Prevention Among Men Who Have Sex With Men (MSM): Result From A Nationwide Survey in Malaysia.

J Community Health. 2023-6

[10]
Optimizing Uptake of Long-Acting Injectable Pre-exposure Prophylaxis for HIV Prevention for Men Who Have Sex with Men.

AIDS Behav. 2023-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索